TP53 and hepatocellular carcinoma: Key clinical benefits included noninvasive assessment of p53 mutation and enhanced interpretability through combined deep learning and clinical parameters.<h4>Conclusion</h4>This VAE-based radiomics framework effectively combines deep feature representation with clinical variables, providing a reliable tool for noninvasive preoperative evaluation of HCC p53 mutation.